Skip to main content
Log in

Correlation Between Proinflammatory Serum Markers: High Sensitivity C-Reactive Protein, Interleukin-6 with Disability Score in Acute Ischemic Stroke

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Stroke being the third leading cause of death and foremost cause of disability, if potential diagnostic utility of blood borne protein biomarkers in predicting acute stroke is established, it would be a substantial adjunct to computerized tomography and magnetic resonance imaging which have their own limitations. This study was done to correlate serum Interleukin 6, high sensitivity C reactive protein at the time of admission with neurological worsening assessed by NIHSS at the time of admission and 7 days after admission. 46 Patients admitted in neurology department SAIMS, Indore with first ever ischemic stroke within 72 h of onset were included in the study. All patients with history of stroke of more than 72 h onset, Infection & peripartum stroke were excluded from the study. Disability scoring was done by NIHSS and their serum samples assayed for hsCRP, IL6 by commercially available quantitative sandwich enzyme-linked immunoadsorbent assay kits. Serum samples of 50 control cases which included healthy volunteers and staff from SAIMS were also analyzed for hsCRP, IL6 for comparative study. A significant correlation was observed between NIHSS scoring and serum hsCRP and IL6 at the time of admission. Patients with initial high serum IL6 and hsCRP also showed significant clinical deterioration as assessed by NIHSS scoring 7 days after admission. Elevated hsCRP and IL6 within 72 h of admission strongly correlated with functional disability in study population in India and may serve as useful adjunct to CT Scan in emergency setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Poungvarin N. Stroke in the developing countries. Lancet. 1998;352(SIII):19–22.

    Article  Google Scholar 

  2. Das SK, Banerjee TK, Biswas A, et al. A prospective community based study of stroke in Kolkata, India. Stroke. 2007;38:906.

    Article  PubMed  Google Scholar 

  3. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics—a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–171.

    Article  PubMed  Google Scholar 

  4. Clark WM. Cytokines and reperfusion injury. Neurology. 1997;49(suppl 4):10–4.

    Google Scholar 

  5. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenic mediator of ischemic brain damage in rats. Stroke. 1995;26:676–81.

    Article  PubMed  CAS  Google Scholar 

  6. Tanne D, Benderly M, Goldbourt U, Hain M, Tenenbaum A, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke. 2006;37:1720–4.

    Article  PubMed  CAS  Google Scholar 

  7. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 2009;40:e380–9.

    Article  PubMed  Google Scholar 

  8. Castellanos M, Leira R, Tejada J, Gil-Peralta A, Davalos A, et al. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry. 2005;76:691–5.

    Article  PubMed  CAS  Google Scholar 

  9. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002;58:624–9.

    PubMed  CAS  Google Scholar 

  10. Dávalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40:1865–9.

    PubMed  Google Scholar 

  11. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, et al. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995;52:670–5.

    PubMed  CAS  Google Scholar 

  12. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156–9.

    Article  PubMed  CAS  Google Scholar 

  13. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM. 2006;99:625–33.

    Article  PubMed  CAS  Google Scholar 

  14. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis. 1999;19:141–55.

    Article  PubMed  CAS  Google Scholar 

  15. Orion D, Schwammenthal Y, Reshef T, et al. Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia. Eur J Neurol. 2008;15:323–8.

    Article  PubMed  CAS  Google Scholar 

  16. Shenhar-Tsarfaty S, Assayag EB, Bova I, et al. Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res. 2008;122(2):167–73.

    Article  PubMed  CAS  Google Scholar 

  17. Smith CJ, Emsley HCA, Gavin CM, et al. Peak plasma interleukin-6, other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume, stroke severity, long-term outcome. BMC Neurol. 2004;4:2.

    Article  PubMed  Google Scholar 

  18. Ferrarese C, Mascarucci P, Zoia C, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cerebr Blood Flow Metab. 1999;19:1004–9.

    CAS  Google Scholar 

  19. Waje-Andreassen U, Kråkenes J, Ulvestad E, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005;112(4):273–4.

    Article  Google Scholar 

  20. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PHM, et al. C-reactive protein, carotid intima media thickness and incidence of stroke in elderly: the Cardiovascular Health Study. Circulation. 2003;108:166–70.

    Article  PubMed  CAS  Google Scholar 

  21. Di Napoli M, Papa F, Bacola V. Prognostic influence of increased C Reactive Protein and fibrinogen levels in ischaemic stroke. Stroke. 2001;32:133–8.

    Article  PubMed  CAS  Google Scholar 

  22. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32:917–24.

    Article  PubMed  CAS  Google Scholar 

  23. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C Reactive protein measurements after first ischemic stroke. Stroke. 2002;33:2459–64.

    Article  PubMed  CAS  Google Scholar 

  24. Kim JS, Kim YI, Lee KS. Relationship between high-sensitivity C-Reactive Protein and clinical functional outcome after acute ischemic stroke in a Korean Population. Cerebrovasc Dis. 2009;28:545–50.

    Article  PubMed  Google Scholar 

  25. Panicker JN, Thomas M, Pavithran K, Nair D, Sarma PS. Morbidity predictors in ischaemic stroke. Neurol India. 2003;51:49–51.

    PubMed  CAS  Google Scholar 

  26. Angerio AD, Bialko MF, White BM. C-reactive protein, stroke, statins. Cardiac Emergencies. Crit Care Nurs Q. 2007;30(2):161–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anuradha Bharosay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bharosay, A., Saxena, K., Varma, M. et al. Correlation Between Proinflammatory Serum Markers: High Sensitivity C-Reactive Protein, Interleukin-6 with Disability Score in Acute Ischemic Stroke. Ind J Clin Biochem 26, 279–282 (2011). https://doi.org/10.1007/s12291-011-0135-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-011-0135-1

Keywords

Navigation